Skip to main content
Log in

Lost productivity from acute myeloid leukaemia a heavy burden in Australia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Parker C, et al. Estimating the Productivity Impact of Acute Myeloid Leukemia in Australia Between 2020 and 2029, Using a Novel Work Utility Measure: The Productivity-Adjusted Life Year (PALY). JCO Oncology Practice : OP2000904, 12 May 2021. Available from: URL: http://doi.org/10.1200/OP.20.00904

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lost productivity from acute myeloid leukaemia a heavy burden in Australia. PharmacoEcon Outcomes News 879, 18 (2021). https://doi.org/10.1007/s40274-021-7741-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7741-9

Navigation